首页 > 市场调查报告书 > 医疗设备

体外诊断感染疾病

尿道感染检测市场规模、份额和成长分析（按检测套组、感染疾病类型、检测类型、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1902067

尿道感染检测市场规模、份额和成长分析（按检测套组、感染疾病类型、检测类型、最终用户和地区划分）－2026-2033年产业预测

Urinary Tract Infection Testing Market Size, Share, and Growth Analysis, By Test Kit (Home Test Kits, Laboratory Test Kits), By Infection Type, By Test Type, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球尿道感染检测市场规模将达到 6.3827 亿美元，到 2025 年将达到 6.6763 亿美元，到 2033 年将达到 9.5673 亿美元，预测期（2026-2033 年）的复合年增长率为 4.6%。

全球尿道感染(UTI) 检测市场正经历显着成长，这主要得益于诊断技术的进步和人们对泌尿道感染（主要影响女性）日益增长的认识。推动该市场成长的关键因素包括尿路感染发病率的上升、医疗费用支出的增加以及人口老化导致老年人更容易感染此类感染疾病。技术创新催生了更精准高效的诊断工具，例如就地检验和非侵入性技术，从而促进了泌尿道感染的检测和管理。此外，个人化医疗的趋势也促使医疗机构采用先进的诊断解决方案，进一步推高了市场需求。然而，儘管医疗保健行业普遍重视感染疾病控制，但某些检测方法的准确性以及替代治疗方案的挑战可能会阻碍因素市场扩张。

推动全球尿道感染检测市场发展的因素

全球尿道感染检测市场成长的主要驱动力是抗生素抗药性尿道感染发生率的上升。抗生素的不合理使用导致了抗药性菌株的出现，进一步加剧了尿道感染的治疗难度。这项严峻挑战促使人们对精准诊断方法的需求日益增长，包括尿液培养和药敏试验，这些方法能够帮助医疗专业人员根据特定致病菌选择最有效的治疗方法。此外，应对抗生素抗药性的迫切需求也推动了对新治疗方法研发的投资，促使市场寻求创新解决方案来对抗抗药性尿道感染，同时倡导合理使用抗生素。

全球尿道感染检测市场面临的限制因素

由于抗生素抗药性问题，全球尿道感染(UTI) 检测市场面临严峻挑战。抗生素的不合理使用和过度处方导致抗药性细菌数量增加，降低了传统 UTI 疗法的疗效。这一持续存在的问题使治疗环境更加复杂，导致感染持续时间延长、医疗成本上升以及严重併发症风险增加。医疗专业人员被要求谨慎管理抗生素的使用，以确保有效治疗，同时倡导合理的处方实践。因此，人们对创新治疗方案和先进诊断方法的需求日益增长，以应对这一重大的公共卫生挑战。

全球尿道感染检测市场趋势

在全球尿道感染(UTI) 检测市场中，照护现场(POC) 解决方案的采用率显着提高，这主要得益于对快速高效诊断的需求。这些 POC 方法使医疗服务提供者能够绕过传统的检查室流程，在诊疗现场即可获得即时结果，从而显着缩短等待检测结果的时间。这一趋势在基层医疗机构尤其有利，因为快速诊断对于有效治疗至关重要。 POC 技术的准确性和效率不断提高，使医疗专业人员能够更快地做出更明智的决策，从而改善患者预后并优化医疗资源。随着这些创新技术的普及，它们正在从根本上重新定义全球 UTI 的诊断方式。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Abbott Laboratories（USA）
Becton, Dickinson and Company（BD）（USA）
bioMerieux SA（France）
Thermo Fisher Scientific Inc.（USA）
Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche Ltd（Switzerland）
Bio-Rad Laboratories, Inc.（USA）
Cepheid（USA）（Parent Company：Danaher Corporation）
Hologic, Inc.（USA）
Quidel Corporation（USA）
Meridian Bioscience, Inc.（USA）
Luminex Corporation（USA）
QIAGEN NV（Netherlands）
Beckman Coulter, Inc.（USA）（Parent Company：Danaher Corporation）
Sysmex Corporation（Japan）
OraSure Technologies, Inc.（USA）
GenMark Diagnostics, Inc.（USA）
Mesa Biotech, Inc.（USA）
Alere Inc.（USA）（Parent Company：Abbott Laboratories）
T2 Biosystems, Inc.（USA）

结论与建议

简介目录

Product Code: SQMIG35D2169

Global Urinary Tract Infection Testing Market size was valued at USD 638.27 Million in 2024 and is poised to grow from USD 667.63 Million in 2025 to USD 956.73 Million by 2033, growing at a CAGR of 4.6% during the forecast period (2026-2033).

The global urinary tract infection (UTI) testing market is experiencing significant growth, driven by advancements in diagnostic technologies and heightened awareness of UTIs, which predominantly affect women. Key factors fueling this market include the increasing incidence of UTIs, rising healthcare expenditures, and an aging population that is more vulnerable to such infections. Innovations in technology are yielding more accurate and efficient diagnostic tools, such as point-of-care tests and non-invasive techniques, facilitating better detection and management of UTIs. Additionally, the trend towards personalized healthcare encourages providers to embrace advanced diagnostic solutions, further increasing demand. Nevertheless, challenges related to the accuracy of certain testing methods and alternative treatment options may pose constraints on market expansion, despite a general focus on infection management within the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinary Tract Infection Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinary Tract Infection Testing Market Segments Analysis

Global Urinary Tract Infection Testing Market is segmented by Test Kit, Infection Type, Test Type, End User and region. Based on Test Kit, the market is segmented into Home Test Kits and Laboratory Test Kits. Based on Infection Type, the market is segmented into Urethritis, Cystitis and Pyelonephritis. Based on Test Type, the market is segmented into Urinalysis, Urine Cultures and Susceptibility Testing. Based on End User, the market is segmented into General Practitioners (GPs), Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories, Hospital Emergency Departments, Urgent Care and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Urinary Tract Infection Testing Market

The global market for urinary tract infection testing is largely propelled by the rising incidence of antibiotic-resistant UTIs. The inappropriate use of antibiotics has resulted in the development of resistant bacterial strains, making UTI management increasingly complex. This critical issue has created a demand for precise diagnostic methods, including urine cultures and susceptibility testing, which allow healthcare professionals to determine the most effective treatment options based on the specific bacteria involved. Furthermore, the pressing need to address antibiotic resistance has stimulated investment in research and development for new therapies, guiding the market towards innovative solutions that tackle resistant UTIs while encouraging responsible antibiotic usage.

Restraints in the Global Urinary Tract Infection Testing Market

The global urinary tract infection (UTI) testing market faces notable challenges due to antibiotic resistance. The inappropriate use and over-prescription of antibiotics have resulted in the rise of drug-resistant bacteria, diminishing the efficacy of traditional treatments for UTIs. This ongoing issue complicates the treatment landscape, leading to prolonged infections, heightened medical expenses, and the potential for serious complications. Healthcare professionals are required to carefully manage the use of antibiotics, ensuring effective treatment while promoting responsible prescribing practices. As a result, there is an increasing demand for innovative therapeutic solutions and advanced diagnostic methods to address this critical public health challenge.

Market Trends of the Global Urinary Tract Infection Testing Market

The global urinary tract infection (UTI) testing market is witnessing a significant shift towards the adoption of Point-of-Care (POC) testing solutions, driven by the need for rapid and efficient diagnostics. These POC methods enable healthcare providers to deliver immediate results at the site of care, bypassing traditional laboratory processes and significantly shortening turnaround times. This trend is particularly beneficial in primary care environments where quick diagnosis is crucial for effective treatment. Enhanced accuracy and efficiency of POC technologies are empowering healthcare professionals to make informed decisions swiftly, thereby improving patient outcomes and optimizing healthcare resources. As these innovations proliferate, they are fundamentally redefining UTI diagnostic practices worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Urinary Tract Infection Testing Market Size by Test Kit & CAGR (2026-2033)

Market Overview
Home Test Kits
Laboratory Test Kits

Global Urinary Tract Infection Testing Market Size by Infection Type & CAGR (2026-2033)

Market Overview
Urethritis
Cystitis
Pyelonephritis

Global Urinary Tract Infection Testing Market Size by Test Type & CAGR (2026-2033)

Market Overview
Urinalysis
Urine Cultures
Susceptibility Testing

Global Urinary Tract Infection Testing Market Size by End User & CAGR (2026-2033)

Market Overview
General Practitioners (GPs)
Urologists
Urogynecologists
Hospital Laboratories
Reference Laboratories
Hospital Emergency Departments
Urgent Care
Others

Global Urinary Tract Infection Testing Market Size & CAGR (2026-2033)

North America (Test Kit, Infection Type, Test Type, End User)
- US
- Canada
Europe (Test Kit, Infection Type, Test Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Kit, Infection Type, Test Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Kit, Infection Type, Test Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Kit, Infection Type, Test Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cepheid (USA) (Parent Company: Danaher Corporation)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter, Inc. (USA) (Parent Company: Danaher Corporation)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OraSure Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenMark Diagnostics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mesa Biotech, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alere Inc. (USA) (Parent Company: Abbott Laboratories)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
T2 Biosystems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments